Literature DB >> 24107916

PPARγ against tumors by different signaling pathways.

Zhi Zhang1, Ying Xu, Qinggang Xu, Yongzhong Hou.   

Abstract

The peroxisome proliferator-activated receptor-γ (PPARγ) belongs to the nuclear hormone receptor superfamily, and is expressed in adipose tissue, skeletal muscle, spleen, heart, liver, placenta, lung, and ovary. PPARγ is a critical regulator of inflammation, adipocyte differentiation, glucose homeostasis, and tumorigenesis. The mechanism of PPARγ on tumor suppression is still unclear, but plenty of evidence shows that PPARγ provides new therapeutic targets for cancer. Here we give a review of how PPARγ and its ligands regulate tumorigenesis by different pathways.
© 2013 S. Karger GmbH, Freiburg

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24107916     DOI: 10.1159/000355328

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  10 in total

Review 1.  Ubiquitin-mediated NFκB degradation pathway.

Authors:  Huimin Xu; Mengli You; Haifeng Shi; Yongzhong Hou
Journal:  Cell Mol Immunol       Date:  2014-10-27       Impact factor: 11.530

2.  PPARδ is a regulator of autophagy by its phosphorylation.

Authors:  Qian Gou; Yidan Jiang; Runyun Zhang; Ying Xu; Huihui Xu; Wenbo Zhang; Juanjuan Shi; Yongzhong Hou
Journal:  Oncogene       Date:  2020-05-21       Impact factor: 9.867

3.  Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells.

Authors:  Tomohiro Kozako; Shuhei Soeda; Makoto Yoshimitsu; Naomichi Arima; Ayako Kuroki; Shinya Hirata; Hiroaki Tanaka; Osamu Imakyure; Nanako Tone; Shin-Ichiro Honda; Shinji Soeda
Journal:  FEBS Open Bio       Date:  2016-04-13       Impact factor: 2.693

4.  Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation.

Authors:  Daniel Savic; Ryne C Ramaker; Brian S Roberts; Emma C Dean; Todd C Burwell; Sarah K Meadows; Sara J Cooper; Michael J Garabedian; Jason Gertz; Richard M Myers
Journal:  Genome Med       Date:  2016-07-11       Impact factor: 11.117

5.  Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy.

Authors:  Shuping Yuan; Jianhua Jin; Lu Chen; Yongzhong Hou; Hong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-15       Impact factor: 2.629

Review 6.  Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy.

Authors:  Qian Gou; Xin Gong; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Oncotarget       Date:  2017-07-27

7.  PPARα Enhances Cancer Cell Chemotherapy Sensitivity by Autophagy Induction.

Authors:  Mengli You; Jiaming Gao; Jianhua Jin; Yongzhong Hou
Journal:  J Oncol       Date:  2018-11-04       Impact factor: 4.375

8.  Differential Expression of Prostaglandin I2 Synthase Associated with Arachidonic Acid Pathway in the Oral Squamous Cell Carcinoma.

Authors:  Anelise Russo; Patrícia M Biselli-Chicote; Rosa S Kawasaki-Oyama; Márcia M U Castanhole-Nunes; José V Maniglia; Dalísio de Santi Neto; Érika C Pavarino; Eny M Goloni-Bertollo
Journal:  J Oncol       Date:  2018-11-08       Impact factor: 4.375

9.  Naoxintong/PPARα Signaling Inhibits H9c2 Cell Apoptosis and Autophagy in Response to Oxidative Stress.

Authors:  Huimin Xu; Jianhua Jin; Lu Chen; Chunxiao Li; Qinggang Xu; Juanjuan Shi; Buchang Zhao; Yongzhong Hou; Hong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-07       Impact factor: 2.629

10.  PPARα Regulates the Proliferation of Human Glioma Cells through miR-214 and E2F2.

Authors:  Yong Gao; Dongfeng Han; Laisheng Sun; Qihua Huang; Guangchao Gai; Zicheng Wu; Wei Meng; Xincheng Chen
Journal:  Biomed Res Int       Date:  2018-05-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.